HCW Biologics Inc (HCWB) — Financial Flexibility Index

Latest as of June 2026: -0.21x

HCW Biologics Inc (HCWB) has a Financial Flexibility Index of -0.21x as of June 2026. Free cash flow of $-3.97 Million (operating CF $-3.97 Million minus capex $4.00) represents 0% of total liabilities ($19.34 Million). Check HCW Biologics Inc (HCWB) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

-0.21x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-3.97 Million
Operating CF − Capex

Total Liabilities

$19.34 Million
USD

Capital Expenditures

$4.00
USD

HCW Biologics Inc Financial Flexibility Index (2019–2025)

Historical Financial Flexibility Index trend for HCW Biologics Inc across 7 annual periods. For the full cash flow conversion analysis, see HCW Biologics Inc (HCWB) cash flow conversion.

Annual Financial Flexibility Index for HCW Biologics Inc (2019–2025)

Year-by-year free cash flow to debt coverage for HCW Biologics Inc. Explore HCWB operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.62x $-13.39 Million $-13.39 Million $21.76 Million ▼ -63.1%
2024 -0.38x $-13.97 Million $-14.23 Million $37.01 Million ▲ +65.2%
2023 -1.08x $-16.31 Million $-22.51 Million $15.05 Million ▼ -9059.7%
2022 -0.01x $-110.98K $-10.39 Million $9.38 Million ▲ +99.7%
2021 -4.71x $-10.93 Million $-10.98 Million $2.32 Million ▲ +54.0%
2020 -10.23x $-10.24 Million $-10.43 Million $1.00 Million ▼ -105.7%
2019 -4.98x $-5.30 Million $-6.77 Million $1.07 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities